OGN
Organon & Co
Organon & Co historical holders
total: 6
Lountzis Asset Management Organon & Co transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2021 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2021 Q4
Paul Lountzis has been an institutional investor in Organon & Co (OGN) since 2021 Q3. According to 2026 Q1 report, Paul Lountzis doesn't hold any shares. The fund/company first acquired OGN in 2021 Q3, initially purchasing 5 shares. Since the initial investment, Lountzis Asset Management has made 1 more transaction in this position.
When did Paul Lountzis exit their OGN position?
Paul Lountzis no longer holds Organon & Co (OGN). They sold off their entire position in 2021 Q4, closing out an investment that began in 2021 Q3.
When did Paul Lountzis first invest in OGN?
Paul Lountzis first invested in Organon & Co (OGN) in 2021 Q3 at the reported quarter-end price of $32.60 per share, acquiring 5 shares in their initial purchase.
What is Paul Lountzis's average cost basis for OGN?
Based on historical transaction data, Paul Lountzis's estimated cost basis for Organon & Co (OGN) is approximately $32.60 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $32.60
- Weighted AVG sell price:
- $32.60
OGN transactions history by Lountzis Asset Management
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q4
|
0.00%
|
0
|
$32.60
|
|
-100% (-5)
|
-0%
|
|
2021 Q3
|
0.00%
|
5
|
$32.60
|
$163
|
new
|
+0%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.